Brief: Orphazyme Provides Regulatory And Financial Updates

Strategic Partners A/S

05/10/2021 08:03

Oct 5 (Reuters) - Orphazyme A/S  ORPHA.CO :
    * ORPHAZYME PROVIDES REGULATORY AND FINANCIAL UPDATES
    * IT NOW EXPECTS TO END 2021 WITH A CASH POSITION OF NO LESS
THAN
DKK 80 MILLION COMPARED TO PRIOR GUIDANCE OF APPROXIMATELY DKK
50 MILLION
    * NOW ANTICIPATES A CHMP OPINION IN Q1 2022 COMPARED TO
PREVIOUS
Q4 2021
    * COMPANY CONTINUES TO ASSESS DIFFERENT POSSIBILITIES FOR
OBTAINING ADDITIONAL FUNDING TO SUSTAIN OPERATIONS IN
LONGER-TERM.
    * EXPECTS TO COMMUNICATE AN UPDATE TO MARKET ONCE IT HAS
RECEIVED
AND ASSESSED FORMAL MINUTES FROM FDA TYPE A MEETING
    * IMPROVED CASH GUIDANCE RELATES TO ONGOING RESTRUCTURING
PLAN

Source text for Eikon:  ID:nGNEbsc1lr 
Further company coverage:  ORPHA.CO 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))